Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Author： Zamboni William   Gervais Anne   Egorin Merrill   Schellens Jan   Zuhowski Elleanor   Pluim Dick   Joseph Erin   Hamburger Deborah   Working Peter   Colbern Gail   Tonda Margaret   Potter Douglas   Eiseman Julie  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.53, Iss.4, 2004-04, pp. : 329-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gamma Camera Imaging of Platinum in Tumours and Tissues of Patients after Administration of 191Pt-Cisplatin

By Areberg Johan   Björkman Sven   Einarsson Lars   Frankenberg Britt   Lundqvist Hans   Mattsson Sören   Norrgren Kristina   Scheike Ole   Wallin Ronnie  

Acta Oncologica, Vol. 38, Iss. 2, 1999-03 ,pp. : 221-228

Informa Healthcare

Access to resources Recommend Favorite

NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression

By              

International Journal of Oncology, Vol. 48, Iss. 1, 2016-01 ,pp. : 225-234

Spandidos Publications

Access to resources Recommend Favorite

Molecular Mechanism Behind the Synergistic Activity of Diphenylmethyl Selenocyanate and Cisplatin Against Murine Tumor Model

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 4, 2015-01 ,pp. : 501-510

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon- after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen

By Atzpodien J.   Lopez Hanninen E.   Kirchner H.   Franzke A.   Korfer A.   Volkenandt M.   Duensing S.   Schomburg A.   Chaitchik S.   Poliwoda H.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 876-881

Elsevier

Access to resources Recommend Favorite

Evaluation of a Prediction Model of Cisplatin Dose Based on Total Platinum Plasma Concentration

By Desoize B.   Berthiot G.   Manot L.   Coninx P.   Dumont P.  

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1734-1738

Elsevier

Access to resources Recommend Favorite